Structure and design of broadly-neutralizing antibodies against HIV

Molecules and Cells

Volumn 34, Issue 3, 2012, Pages 231-237

  Ryu, Seong Eon ^a   Hendrickson, Wayne A ^b  

^a Hanyang University   (South Korea)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Broadly neutralizing antibody; Design; HIV; Structure; Vaccine

Indexed keywords

CD4 ANTIBODY; F105 ANTIBODY; GLYCOPROTEIN GP 120; HEMAGGLUTININ; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY B12; MEMBRANE PROTEIN; NEUTRALIZING ANTIBODY; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; VRC01 ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY COMBINING SITE; COMPLEMENTARITY DETERMINING REGION; CRYSTAL STRUCTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOTHERAPY; PASSIVE IMMUNIZATION; PROTEIN INTERACTION; REVIEW; VACCINATION; VIRUS ISOLATION; VIRUS STRAIN;

AIDS VACCINES; ANTIBODIES, NEUTRALIZING; ANTIGENS, CD4; BINDING SITES; DRUG DESIGN; HIV; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HUMANS; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84870317596     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-012-0104-4     Document Type: Review

References (49)

1. Azoitei, M.L., Correia, B.E., Ban, Y.E., Carrico, C., Kalyuzhniy, O., Chen, L., Schroeter, A., Huang, P.S., McLellan, J.S., Kwong, P.D., et al. (2011). Computation-guided backbone grafting of a discontinuous motif onto a protein scaffold. Science 334, 373-376.
2. Baker, D. (2010). An exciting but challenging road ahead for computational enzyme design. Protein Sci. 19, 1817-1819.
3. Barre-Sinoussi, F., Chermann, J.C., Rey, F., Nugeyre, M.T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vezinet-Brun, F., Rouzioux, C., et al. (1983). Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220, 868-871.
4. Burton, D.R., Pyati, J., Koduri, R., Sharp, S.J., Thornton, G.B., Parren, P.W., Sawyer, L.S., Hendry, R.M., Dunlop, N., Nara, P. L., et al. (1994). Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266, 1024-1027.
5. Calarese, D.A., Scanlan, C.N., Zwick, M.B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., Wormald, M.R., Stanfield, R.L., Roux, K.H., et al. (2003). Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300, 2065-2071.
6. Chao, G., Lau, W.L., Hackel, B.J., Sazinsky, S.L., Lippow, S.M., and Wittrup, K.D. (2006). Isolating and engineering human antibodies using yeast surface display. Nat. Protoc. 1, 755-768.
7. Chen, B., Vogan, E.M., Gong, H., Skehel, J.J., Wiley, D.C., and Harrison, S.C. (2005). Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 433, 834-841.
8. Chen, L., Kwon, Y.D., Zhou, T., Wu, X., O'Dell, S., Cavacini, L., Hessell, A.J., Pancera, M., Tang, M., Xu, L., et al. (2009). Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120. Science 326, 1123-1127.
9. Chi, S.W., Maeng, C.Y., Kim, S.J., Oh, M.S., Ryu, C.J., Han, K.H., Hong, H.J., and Ryu, S.E. (2007). Broadly neutralizing antihepatitis B virus antibody reveals a complementarity determining region H3 lid-opening mechanism. Proc. Natl. Acad. Sci. USA 104, 9230-9235.
10. Cordonnier, A., Montagnier, L., and Emerman, M. (1989). Single amino-acid changes in HIV envelope affect viral tropism and receptor binding. Nature 340, 571-574.
11. Correia, B.E., Ban, Y.E., Holmes, M.A., Xu, H., Ellingson, K., Kraft, Z., Carrico, C., Boni, E., Sather, D.N., Zenobia, C., et al. (2010). Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope. Structure 18, 1116-1126.
12. Diskin, R., Scheid, J.F., Marcovecchio, P.M., West, A.P., Jr., Klein, F., Gao, H., Gnanapragasam, P.N., Abadir, A., Seaman, M.S., Nussenzweig, M.C., et al. (2011). Increasing the potency and breadth of an HIV antibody by using structure-based rational design. Science 334, 1289-1293.
13. Fleishman, S.J., Whitehead, T.A., Ekiert, D.C., Dreyfus, C., Corn, J.E., Strauch, E.M., Wilson, I.A., and Baker, D. (2011). Computational design of proteins targeting the conserved stem region of influenza hemagglutinin. Science 332, 816-821.
14. Gallo, R.C., Salahuddin, S.Z., Popovic, M., Shearer, G.M., Kaplan, M., Haynes, B.F., Palker, T.J., Redfield, R., Oleske, J., Safai, B., et al. (1984). Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224, 500-503.
15. Gonzalez, N., Alvarez, A., and Alcami, J. (2010). Broadly neutralizing antibodies and their significance for HIV-1 vaccines. Curr. HIV Res. 8, 602-612.
16. Harris, A., Borgnia, M.J., Shi, D., Bartesaghi, A., He, H., Pejchal, R., Kang, Y.K., Depetris, R., Marozsan, A.J., Sanders, R.W., et al. (2011). Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures. Proc. Natl. Acad. Sci. USA 108, 11440-11445.
17. Haynes, B.F., Fleming, J., St Clair, E.W., Katinger, H., Stiegler, G., Kunert, R., Robinson, J., Scearce, R.M., Plonk, K., Staats, H.F., et al. (2005). Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 308, 1906-1908.
18. Hessell, A.J., Hangartner, L., Hunter, M., Havenith, C.E., Beurskens, F.J., Bakker, J.M., Lanigan, C.M., Landucci, G., Forthal, D.N., Parren, P.W., et al. (2007). Fc receptor but not complement binding is important in antibody protection against HIV. Nature 449, 101-104.
19. Hessell, A.J., Rakasz, E.G., Poignard, P., Hangartner, L., Landucci, G., Forthal, D.N., Koff, W.C., Watkins, D.I., and Burton, D.R. (2009). Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers. PLoS Pathog. 5, e1000433.
20. Ju, S.M., Goh, A.R., Kwon, D.J., Youn, G.S., Kwon, H.J., Bae, Y.S., Choi, S.Y., and Park, J. (2012). Extracellular HIV-1 Tat induces human beta-defensin-2 production via NF-kappaB/AP-1 dependent pathways in human B cells. Mol. Cells 33, 335-341.
21. Korber, B., Muldoon, M., Theiler, J., Gao, F., Gupta, R., Lapedes, A., Hahn, B.H., Wolinsky, S., and Bhattacharya, T. (2000). Timing the ancestor of the HIV-1 pandemic strains. Science 288, 1789-1796.
22. Kwon, Y.D., Finzi, A., Wu, X., Dogo-Isonagie, C., Lee, L.K., Moore, L.R., Schmidt, S.D., Stuckey, J., Yang, Y., Zhou, T., et al. (2012). Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops. Proc. Natl. Acad. Sci. USA 109, 5663-5668.
23. Kwong, P.D., Wyatt, R., Robinson, J., Sweet, R.W., Sodroski, J., and Hendrickson, W.A. (1998). Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648-659.
24. Kwong, P.D., Wyatt, R., Majeed, S., Robinson, J., Sweet, R.W., Sodroski, J., and Hendrickson, W.A. (2000). Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. Structure 8, 1329-1339.
25. Kwong, P.D., Doyle, M.L., Casper, D.J., Cicala, C., Leavitt, S.A., Majeed, S., Steenbeke, T.D., Venturi, M., Chaiken, I., Fung, M., et al. (2002). HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 420, 678-682.
26. Lane, H.C. (2010). Pathogenesis of HIV infection: Total CD4+ T-cell pool, immune activation, and inflammation. Top HIV Med. 18, 2-6.
27. Liu, J., Bartesaghi, A., Borgnia, M.J., Sapiro, G., and Subramaniam, S. (2008). Molecular architecture of native HIV-1 gp120 trimers. Nature 455, 109-113.
28. Looger, L.L., Dwyer, M.A., Smith, J.J., and Hellinga, H.W. (2003). Computational design of receptor and sensor proteins with novel functions. Nature 423, 185-190.
29. Madani, N., Schon, A., Princiotto, A.M., Lalonde, J.M., Courter, J.R., Soeta, T., Ng, D., Wang, L., Brower, E.T., Xiang, S.H., et al. (2008). Small-molecule CD4 mimics interact with a highly conserved pocket on HIV-1 gp120. Structure 16, 1689-1701.
30. Mascola, J.R., Stiegler, G., VanCott, T.C., Katinger, H., Carpenter, C.B., Hanson, C.E., Beary, H., Hayes, D., Frankel, S.S., Birx, D.L., et al. (2000). Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6, 207-210.
31. McLellan, J.S., Pancera, M., Carrico, C., Gorman, J., Julien, J.P., Khayat, R., Louder, R., Pejchal, R., Sastry, M., Dai, K., et al. (2011). Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature 480, 336-343.
32. Ofek, G., Tang, M., Sambor, A., Katinger, H., Mascola, J.R., Wyatt, R., and Kwong, P.D. (2004). Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J. Virol. 78, 10724-10737.
33. Ofek, G., Guenaga, F.J., Schief, W.R., Skinner, J., Baker, D., Wyatt, R., and Kwong, P.D. (2010). Elicitation of structure-specific antibodies by epitope scaffolds. Proc. Natl. Acad. Sci. USA 107, 17880-17887.
34. Olshevsky, U., Helseth, E., Furman, C., Li, J., Haseltine, W., and Sodroski, J. (1990). Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J. Virol. 64, 5701-5707.
35. Ryu, S.E., Kwong, P.D., Truneh, A., Porter, T.G., Arthos, J., Rosenberg, M., Dai, X.P., Xuong, N.H., Axel, R., Sweet, R.W., et al. (1990). Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature 348, 419-426.
36. Sanders, R.W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K.O., Kwong, P.D., and Moore, J.P. (2002). The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J. Virol. 76, 7293-7305.
37. Sattentau, Q.J., and Weiss, R.A. (1988). The CD4 antigen: Physiological ligand and HIV receptor. Cell 52, 631-633.
38. Scheid, J.F., Mouquet, H., Ueberheide, B., Diskin, R., Klein, F., Oliveira, T.Y., Pietzsch, J., Fenyo, D., Abadir, A., Velinzon, K., et al. (2011). Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333, 1633-1637.
39. Siegel, J.B., Zanghellini, A., Lovick, H.M., Kiss, G., Lambert, A.R., St Clair, J.L., Gallaher, J.L., Hilvert, D., Gelb, M.H., Stoddard, B.L., et al. (2010). Computational design of an enzyme catalyst for a stereoselective bimolecular Diels-Alder reaction. Science 329, 309-313.
40. Starcich, B.R., Hahn, B.H., Shaw, G.M., McNeely, P.D., Modrow, S., Wolf, H., Parks, E.S., Parks, W.P., Josephs, S.F., Gallo, R.C., et al. (1986). Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell 45, 637-648.
41. Swetnam, J., Shmelkov, E., Zolla-Pazner, S., and Cardozo, T. (2010). Comparative magnitude of cross-strain conservation of HIV variable loop neutralization epitopes. PLoS One 5, e15994.
42. Thali, M., Furman, C., Ho, D.D., Robinson, J., Tilley, S., Pinter, A., and Sodroski, J. (1992). Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein. J. Virol. 66, 5635-5641.
43. Wang, J.H., Yan, Y.W., Garrett, T.P., Liu, J.H., Rodgers, D.W., Garlick, R.L., Tarr, G.E., Husain, Y., Reinherz, E.L., and Harrison, S.C. (1990). Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 348, 411-418.
44. Wilen, C.B., Tilton, J.C., and Doms, R.W. (2012). Molecular mechanisms of HIV entry. Adv. Exp. Med. Biol. 726, 223-242.
45. Wu, X., Yang, Z.Y., Li, Y., Hogerkorp, C.M., Schief, W.R., Seaman, M.S., Zhou, T., Schmidt, S.D., Wu, L., Xu, L., et al. (2010). Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329, 856-861.
46. Wyatt, R., Kwong, P.D., Desjardins, E., Sweet, R.W., Robinson, J., Hendrickson, W.A., and Sodroski, J.G. (1998). The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393, 705-711.
47. Xie, H., Ng, D., Savinov, S.N., Dey, B., Kwong, P.D., Wyatt, R., Smith, A.B., 3rd, and Hendrickson, W.A. (2007). Structure-activity relationships in the binding of chemically derivatized CD4 to gp120 from human immunodeficiency virus. J. Med. Chem. 50, 4898-4908.
48. Zhou, T., Xu, L., Dey, B., Hessell, A.J., Van Ryk, D., Xiang, S.H., Yang, X., Zhang, M.Y., Zwick, M.B., Arthos, J., et al. (2007). Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 445, 732-737.
49. Zhou, T., Georgiev, I., Wu, X., Yang, Z.Y., Dai, K., Finzi, A., Kwon, Y.D., Scheid, J.F., Shi, W., Xu, L., et al. (2010). Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 329, 811-817.